TNFSF13 and central nervous system cancer: Moreover, TNFSF13 was remarkably upregulated in CL and ME subtypes compared with other subtypes among gliomas, which immune checkpoint inhibitors and immunosuppressive cytokines were enriched in ME subtype to facilitate immunosuppression and tumor invasion (49, 64).